Preclinical safety evaluation of the aqueous acetone extract of Chinese herbal formula Modified Huo Luo Xiao Ling Dan.
OBJECTIVE
To investigate the safety of oral administration of Modified Huo Luo Xiao Ling Dan (HLXLD), a compound traditional Chinese herbal medicine.


METHODS
The toxicological information of HLXLD and its individual constituent herbs was searched in cintcm or TCMlars (www.cintcm.com), PubMed (MEDLINE), Chinese Herbal Medicine (1999) and WHO Monographs on Selected Medicinal Plants (Vol. I- III). Single-dose acute toxicity was assessed by using the highest possible dosage. Motor function test was used to determine whether the herbal formula might cause motor impairment. Nine-day HLXLD repeat-dose sub-chronic toxicity/adverse effects, and 42-day chronic toxicity/adverse effects in rats were also assessed.


RESULTS
The literature searches showed that HLXLD and its eleven ingredient herbs had no side/adverse effects listed in the traditional Chinese medicine literature. Under the dosages proposed in the formula, the HLXLD formula had no side/adverse effects according to MEDLINE, Chinese Herbal Medicine and WHO Monographs on Selected Medicinal Plants. The studies in rats showed: (1) in single-dose acute toxicity assessment, the maximal feasible single oral dose, 9.20 g/kg HLXLD, showed no significant effect on clinical signs, or body weight and mortality over a 14-day period in rats; (2) during motor function test, nine-day repeat-dose of daily HLXLD treatment at 4.60 g/kg did not cause motor impairment; (3) in nine-day HLXLD repeat-dose sub-chronic toxicity/adverse effects assessment, there were no noticeable abnormal behavioral changes or obvious adverse reactions and signs in complete Freund's adjuvant inflamed rats (highest observed dosage: 4.60 g/kg), and no noticeable adverse effects were observed during, or 14 days after nine-day treatment at 4.60 g/kg in non-inflamed rats; (4) during 42-day chronic toxicity/adverse effects assessments, no noticeable abnormal behavioral changes, no obvious adverse reactions and signs were observed in normal rats administered with HLXLD at a dose of 2.30 g/kg and the values of serum biochemistry and histopathology were in normal range.


CONCLUSIONS
Both existing information and animal data support that Modified HLXLD is a safe herbal product for clinical application.
Fan
Arthur Yin
AY
Center for Integrative Medicine, University of Maryland, Baltimore, MD 21201, USA. ArthurFan@ChineseMedicineDoctor.US
Lao
Lixing
L
Zhang
Rui-xin
RX
Zhou
An-nan
AN
Berman
Brian M
BM
D000818:Animals; D004353:Drug Evaluation, Preclinical; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000009:adverse effects*; D010936:Plant Extracts / Q000008:administration & dosage / Q000009:adverse effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D036401:Toxicity Tests, Chronic
D004365:Drugs, Chinese Herbal; D010936:Plant Extracts; C547651:huo luo xiao ling dan
J Ethnopharmacol. 2005 Oct 3;101(1-3):104-9
15970410
Am J Chin Med. 2006;34(5):833-44
17080548
Zhongguo Zhong Yao Za Zhi. 2001 Jun;26(6):369-72
12528501
Encephale. 2004 Sep-Oct;30(5):417-24
15627046
Photodermatol Photoimmunol Photomed. 1991 Apr;8(2):84-5
1756118
Pain. 1983 Jun;16(2):109-110
6877845
J Clin Psychiatry. 2005 Feb;66(2):260-4
15705014
J Altern Complement Med. 2005 Apr;11(2):323-31
15865500
Rheumatology (Oxford). 2003 May;42(5):665-72
12709543
J Pain. 2001 Apr;2(2):111-7
14622832
J Hum Hypertens. 2001 Aug;15(8):549-52
11494093
Am J Health Syst Pharm. 2000 Jul 1;57(13):1221-7; quiz 1228-30
10902065
J Altern Complement Med. 1999 Oct;5(5):429-36
10537242
J Ethnopharmacol. 2009 Jan 30;121(3):366-71
19100323
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1994 Oct;14(10):583-5
7719087
Adv Data. 2004 May 27;(343):1-19
15188733